Rates of gestational diabetes mellitus vary by state

Rates of gestational diabetes mellitus vary by state
Obesity, age, race/ethnicity, hospital characteristics, and insurance type may contribute to the variability in rates of gestational diabetes mellitus between states, according to research published in the May issue of Diabetes Care.

(HealthDay)—Obesity, age, race/ethnicity, hospital characteristics, and insurance type may contribute to the variability in rates of gestational diabetes mellitus (GDM) between states, according to research published in the May issue of Diabetes Care.

Barbara H. Bardenheier, Ph.D., M.P.H., of the U.S. in Atlanta, and colleagues analyzed data from the Healthcare Cost and Utilization Project State Inpatient Databases for 23 states to identify factors that contribute to variability in the rates of GDM between states.

The researchers found that rates of GDM per 100 deliveries, adjusted by age and by race, varied from 3.47 in Utah to 7.15 in Rhode Island. The major factors explaining the variability in GDM rates at the state level were the proportion of obese women (27.4 percent), hospital characteristics (17.6 percent), age (14.7 percent), race/ethnicity (11.8 percent), and insurance type (5.9 percent).

"Differences in GDM rates at the state level that are mostly driven by race/ethnicity, obesity, and hospital-level factors call for public health action," the authors write. "Our findings suggest that a large proportion of GDM could be avoided with prevention of among women of childbearing age."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

BMI thresholds for gestational diabetes differ by race

date Jun 01, 2012

(HealthDay) -- There is considerable racial/ethnic variation in the prevalence of gestational diabetes mellitus (GDM) by body mass index (BMI), according to a study published online May 22 in Diabetes Care.

Recommended for you

Adapted diabetes prevention program deemed effective

date Jul 06, 2015

(HealthDay)—An adapted Diabetes Prevention Program (DPP) lifestyle intervention significantly improves cardiovascular disease-related risk factors among participants, according to a study published in the ...

Diabetes drug helps people lose weight: study

date Jul 01, 2015

Liraglutide, an injectable diabetes drug that US regulators approved last year for weight loss, helped obese people lose an average of 18 pounds (eight kilograms), a yearlong study said Wednesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.